Sunday, May 28, 2017
 
 
Company News: Page (1) of 1 - 03/17/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Innophos 2017 Investor Day Rescheduled For April 5th
Company to Unveil New Strategic Growth Roadmap and Long-term Financial TargetsEvent to be Webcast Live on April 5 at 8:30 a.m. ET
(March 17, 2017)

CRANBURY, N.J., March 17, 2017 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ: IPHS), a leading international producer of specialty ingredient solutions, today announced that it will hold and webcast its Investor Day for investors and analysts on April 5, 2017 from 8:30 a.m. to approximately 12:00 p.m. ET. The Company had previously postponed the event due to severe winter weather in the New York City area.  At the event, Innophos' management team will unveil the Company's strategic roadmap and long term growth prospects.

The live audio webcast and presentation slides will be accessible in the "Investors" section of Innophos' website.  The event will be archived on the Company's website for approximately one year. 

For those investors and analysts interested in attending the event, please RSVP via email to IPHS@InvestorRelations.com.  The event will be limited to investors and analysts only. All participants must be registered in advance to attend, as space is limited.


About Innophos
Innophos is a leading international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition and industrial markets. We leverage our expertise in the science and technology of blending and formulating phosphate, mineral and botanical based ingredients to help our customers offer products that are tasty, healthy, nutritious and economical. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations across the United States, in Canada, Mexico and China. For more information, please visit www.innophos.com. 'IPHS-G'

Investor Contact                                    

Media Contact          


Mark Feuerbach                                          

Ryan Flaim                 


Innophos                                                      

Sharon Merrill Associates 


609-366-1204                                               

617-542-5300    


investor.relations@innophos.com                 

iphs@investorrelations.com 


To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/innophos-2017-investor-day-rescheduled-for-april-5th-300425516.html

SOURCE Innophos Holdings, Inc.

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Science, Email,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • Silver Birch of Hammond Affordable Assisted Lifestyle Community Opens Doors
  • NetDirector Enables Next-Generation Integration in Radiology with American Health Imaging
  • APR Applied Pharma Research at the 9th ChinaBio® Partnering Forum: Bringing Swiss Made Innovations and Science Driven Technologies to Strengthen Its Presence in the Chinese Market
  • Medical Imaging Equipment Market Is Expected To Reach USD 44,887.4 Mn By 2022, Credence Research
  • Growth Opportunities in the Global Diagnostic Imaging Market, 2017-2022 - Research and Markets

    Cancer
  • Cone beam computed tomography (CBCT) Systems Market Expected to Reach $1,041 Million, Globally, by 2023 - Allied Market Research
  • Mesothelioma Compensation Center Now Urges the Family of a Person Who Recently Died From Mesothelioma Before They Could Hire a Lawyer to File a Claim to Call for Instant Help
  • Mapi Research Trust Unveils New Clinical Outcome Assessments (COA) Website for the Zarit Burden Interview (ZBI) Questionnaire
  • Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010 - 2017: Deal trends, players, financials and forecasts
  • Artificial Intelligence Firm Set to Revolutionize Healthcare
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines